Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation to Overcome Severe Restless Legs Syndrome (NO RLS)

NCT07780032 is registered in ClinicalTrials.gov with Marshall Holland as lead sponsor.

NCT NCT07780032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07780032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation to Overcome Severe Restless Legs Syndrome (NO RLS)
Lead sponsor
Marshall Holland
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2027
Completion date
October 31, 2034
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

restless leg syndrome (rls), spinal cord stimulation (scs)